TNFSF11 and prostate cancer: We cultured RAW 264.7 monocytes for 4 days untreated as negative control, treated with RANKL (50 ng/ml) as positive control, or supplemented with 10% serum free CM of prostate cancer cells, PC3 or LNCaP (Figure 1A).